Nautilus Biotechnolgy (NAUT)
NASDAQ:NAUT
US Market
Holding NAUT?
Track your performance easily

Nautilus Biotechnolgy (NAUT) Financial Statements

119 Followers

Nautilus Biotechnolgy Financial Overview

Nautilus Biotechnolgy's market cap is currently ―. The company's EPS TTM is $-0.56; its P/E ratio is -4.71; Nautilus Biotechnolgy is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue---$ 48.66M$ 41.75M
Gross Profit---$ 9.95M$ 8.65M
EBIT$ -16.45M$ -18.01M$ -20.00M$ -10.95M$ -1.95M
EBITDA$ -14.85M$ -15.67M$ -18.41M$ -7.85M$ 1.20M
Net Income Common Stockholders$ -16.45M$ -18.01M$ -17.02M$ -12.54M$ -4.92M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 140.61M$ 167.44M$ 173.42M$ 8.13M$ 17.33M
Total Assets$ 259.70M$ 272.75M$ 305.56M$ 167.68M$ 140.18M
Total Debt$ 31.57M$ 32.60M$ 34.63M$ 34.66M$ 35.96M
Net Debt$ -109.04M$ -134.84M$ -138.79M$ 26.53M$ 18.63M
Total Liabilities$ 36.27M$ 37.47M$ 40.21M$ 120.56M$ 81.11M
Stockholders Equity$ 223.43M$ 235.26M$ 265.35M$ 47.12M$ 59.07M
Cash Flow-
Free Cash Flow$ -13.82M$ -15.97M$ -14.31M$ -6.29M$ 6.96M
Operating Cash Flow$ -13.11M$ -15.46M$ -13.90M$ -5.57M$ -2.37M
Investing Cash Flow$ -7.50M$ 14.29M$ -41.06M$ -724.00K$ 11.67M
Financing Cash Flow$ 140.00K$ 319.00K$ 253.00K$ -320.00K$ -9.52M
Currency in USD

Nautilus Biotechnolgy Earnings and Revenue History

Nautilus Biotechnolgy Debt to Assets

Nautilus Biotechnolgy Cash Flow

Nautilus Biotechnolgy Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis